ABSTRACT
The ability of recombinant DNA viruses to transfer genes into hematopoietic cells has been explored. A recombinant simian virus 40 (SV40) in which the early region had been replaced with the chloramphenicol acetyltransferase (CAT) gene driven by the promoter from Rous sarcoma virus (RSV), was constructed. This virus transferred the CAT gene more efficiently into mouse and human bone marrow cells and into the K562, MEL, and WEHI hematopoietic tissue culture cell lines, than the classical calcium phosphate DNA transfer procedure, as shown by assay for CAT activity 48 hr after infection. Recombinant SV40 virions were also shown to be capable of stably transforming Chinese hamster ovary cells by use of an early region recombinant containing the methotrexate-resistant dihydrofolate reductase (DHFR) gene driven by the RSV promoter. The entire DHFR transcriptional unit could be detected in the genome of transformed cells that were also shown to be resistant to methotrexate. A recombinant adenovirus stock containing the neomycinresistance gene driven by the SV40 early promoter was used to infect the K562 and MEL hematopoietic cell lines to resistance to the antibiotic G418. Transformation frequency was 10-to 100-fold higher than that obtained with calcium phosphateprecipitated DNA. Most or all of the recombinant adenovirus genome was integrated as 1-3 copies in the transformed cells. These studies show the feasibility of using DNA viruses for introduction of new genetic material into hematopoietic cells.
Recombinant viral vectors may offer several advantages for transfer of genetic information into animal cells compared to the most frequently used method that utilizes calcium phosphate (CaPO4)-precipitated DNA (1) . Among these advantages are a higher efficiency of gene transfer, particularly for suspension cells, possible specificity for certain cell types, and the potential for introducing only one or two copies of new genetic information.
Retroviral vectors have been used to introduce genes into enzyme-deficient cells (2) (3) (4) (5) . Recently, transfer of new genetic information into hematopoietic cells of mice has been achieved with a recombinant retrovirus (6) . Rearrangement of intron-containing genes (7) and the inhibiting effects of promoter and polyadenylylation (3, 6 ) signals on the propagation of recombinant retroviral genomes may limit the usefulness of this approach. Recombinant simian virus 40 (SV40) viruses have been useful mainly for study of gene expression in short-term assays (8, 9) , an application largely superseded by the ability to study gene expression after CaPO4-mediated transfer of recombinant plasmid DNA into tissue culture cells (10, 11) . Cell transformation due to integration of portions of the SV40 genome after infection by SV40 is a well described phenomenon and suggests that appropriate recombinant SV40 virions could be used for gene transfer (12) . The papilloma virus has the advantage that it replicates as an episome (13) . Recombinant adenoviruses have recently been used as vehicles for high efficiency transfer' of either the SV40 early region (14) or the gene that confers neomycin resistance (15) into tissue culture cells.
Recombinant virus stocks can be obtained by use of defective helper viruses or by use of a permissive cell line into which a complementing portion of viral genome has been integrated. Such cell lines are already available for preparation of recombinant retroviral stocks (16) . The Cos cell lines (17) can replicate molecules containing a SV40 origin (18) but do not express T antigen at a level sufficient to allow preparation of high titer SV40 viral stocks. Deletion mutants of adenovirus lacking the ElA region are complemented by ElA protein production in the human kidney cell line 293 (19) . The 293 cell line can be used to prepare helper-free adenovirus stocks containing up to 6 kilobases (kb) of inserted foreign DNA (14, 20) .
Our interest is the introduction of eukaryotic genes containing introns into hematopoietic cells. Recombinant SV40 vectors were shown to be efficient for achieving transient gene expression in hematopoietic cells. However, the propensity of the complementing SV40 molecules present in viral preparations to undergo recombination with generation of wild-type SV40 prevented use of these vectors for stable gene transfer. Hence, we explored the use of adenoviruses to achieve this purpose. 
METHODS

159
Construction of SV40 Recombinants. Fig. 1 shows a map of a SV40 recombinant containing the chloramphenicol acetyltransferase gene (SV-CAT) and the methotrexateresistant DHFR gene (SV-DHFRMtxR). The plasmids pUSV-CAT and pUSV-DHFRMtxR containing the recombinant SV40 genomes were each made from three DNA fragments, a SV40 piece, a linearized pUC9 plasmid, and the inserted gene. To construct SV-CAT, pRSV-CAT (24, 25) (obtained from B. Howard and C. Gorman) was used. The plasmid pUSV-CAT was identified; restriction of plasmid DNA with BamHI released a 5.2-kb fragment that could be cyclized by ligation at a low DNA concentration (1 jig/ml). SVDHFRMtXR was created by an identical strategy except the DHFRMtXR coding sequence, isolated from pFR 400-12 (26) (obtained from C. Simonsen), was used for the construction of pUSV-DHFRM XR, from which the SV-DHFRMtxR genome was prepared.
Preparation of the viral stocks SV-CAT and SVDHFRMtXR required a complementing helper virus with an intact early region. We used a viral genome (SV-STN DHFR) in which the SV40 late region sequences 1483 (HindIII) to 2533 (BamHI) had been replaced with normal mouse DHFR coding sequences derived from pDHFR26 (8, 27) . GMK cells were transfected with an equal molar mixture of early region and late region recombinant viral genomes in DEAE-dextran (0.67 mg/ml) using standard techniques. Hirt Preparation of the recombinant adenovirus 5 containing the neomycin resistance (NeoR) gene in human embryonic kidney 293 cells that produce the ElA protein (19) has already been described in detail (15, 20) . The viral lysate used in these experiments has a titer of 109 plaque-forming units on 293 cells.
Cell Transformation. Cells were infected with SV-CAT by exposure of 106 (cell lines) or 2-10 x 108 (bone marrow) cells to 1 ml of secondary viral lysate for 1 hr at 37°C. An equal number of cells in a 50-cm2 Petri dish were exposed to a precipitate containing 10 ,ug of pUSV-CAT, 10 ,ug of pSTN 9a-DHFR (complementing helper), and 20 ,tg of salmon sperm DNA. Cells were harvested for the CAT assay after 48 hr (24) .
CHO DG 21 cells were infected with SV-DHFRMtxR by exposure of 5 x 105 cells to 1 ml of secondary viral lysate for 4 hr. Subsequently, the cells were grown in medium lacking hypoxanthine/glycine/thymidine. Transformation of the adherent and floating MEL cell lines with the SV-DHFRMtxR stock was attempted by similar methods, although selection was in 0.4 AM methotrexate (Lederle Laboratories, Pearl River, NY). Adherent and "floating" K562 and MEL cells were infected with adenovirus-NeoR (15) ; 106 cells in logarithmic phase were exposed to virus at a multiplicity of infection of 400 plaque-forming units per cell in 1 ml of appropriate medium in a shaking air bath at 37°C for 1 hr. The cells were washed and resuspended in medium for 24 hr and then 102_104 cells were plated in individual microtiter wells in medium containing G418 (GIBCO) at a concentration of 1 mg/ml. DNA samples prepared by standard methods from cell clones were analyzed by the Southern blotting method.
RESULTS
Infection of Adherent and Hematopoietic Cells with SV-
CAT. Fig. 2 shows data from seven cell lines tested, three adherent cell lines that grow as a monolayer (a) and four hematopoietic cell lines that grow in suspension (b). CAT activity was much higher in permissive GMK cells infected with SV-CAT than in GMK cells exposed to CaPO4 DNA precipitate containing pUSV-CAT (and pSTN 9a-DHFR). Both semipermissive HeLa and nonpermissive L-cells expressed more CAT activity after exposure of CaPO4-precipitated DNA than after exposure to virus. In contrast, SV-CAT was much more effective in transferring CAT activity into each of the hematopoietic cell lines than was the CaPO4 DNA precipitate. Identical results were obtained in three separate experiments. The two methods for transferring the CAT transcriptional unit were also compared on mouse and human bone marrow cells (Fig. 3) . SV-CAT infection gave readily detectable enzyme activity after 48 hr but exposure of marrow cells to CaPO4-precipitated plasmid DNA gave little activity in mouse cells and no activity in human cells.
Transformation clonal population had integrated a single copy of wild-type SV40 genome (data not shown).
Transformation of K562 and MEL Cells Using AdenovirusNeoR. Both adherent and suspension K562 and MEL cells were readily transformed to G418 resistance with adenovirusNeoR. For comparison, transfections were also carried out using CaPOfprecipitated pSV2neo DNA, which contains a similar Neo transcriptional unit to the one in the recombinant adenovirus. In two separate experiments, the transformation frequency with the recombinant adenovirus was 10-to 100-fold greater than that obtained by CaPO4-mediated DNA transfer. DNA derived from G418-resistant colonies (Fig. 4) The same filters were annealed to the adenovirus DNA probe. The K562 cell lines were found to contain adenovirus DNA sequences prior to infection that hybridized with the adenovirus probe (Fig. SA) . A reconstitution experiment was performed in which one or three genome equivalents of the adenovirus-NeoR DNA was mixed with DNA from uninfected K562 cells, cut with HindIII or Sst I and probed with adenovirus 5 DNA. The restriction endonuclease pattern of the recombinant viral DNA was compared with that of the two transformed K562 clones (Fig. SA) . Both clones contain all the internal HindIII and Sst I fragments, indicating that the whole genome of the adenovirus-NeoR has integrated into the chromosomes of the transformed cells. The intensity of the hybridizing bands implies integration of one to three copies per chromosome.
The DNA from two transformed MEL clones showed the expected hybridization pattern with the Neo probe (Fig. 5B) , but the pattern detected with the adenovirus 5 probe was more complex (data not shown). One MEL clone had most of the adenoviral recombinant integrated, whereas the other had only a part of the viral genome integrated, suggesting significant deletion and/or rearrangement of the vector genome during integration. In contrast to the K562 uninfected control, no bands were detected in the control MEL DNA using the adenovirus probe.
DISCUSSION
Our studies imply that the recombinant DNA viruses used here offer a dramatic improvement in the efficiency of gene transfer into the hematopoietic cells used here compared to CaPO4-mediated DNA transfer. Both transient expression of the CAT gene with recombinant SV40 virus and stable transformation to neomycin (G-418) resistance with recombinant adenovirus was readily achieved on infection of hematopoietic cells. We do not know, however, which cell types in the mixed population of bone marrow cells became infected with SV-CAT and actively expressed the CAT gene. Apparent recombination of the viral genome containing CAT or DHFRM'XR in the early region and the recombinant SV40 genome containing DHFR in the late region led to contamination of the recombinant SV40 stocks with wild-type SV40. Attempts to transform cells containing a normal DHFR gene to methotrexate-resistance with stocks containing SVDHFRMtXR resulted in stable integration of wild-type SV4C rather than SV-DHFRMtxR. In contrast, pure recombinant adenovirus stocks were highly efficient in transforming hematopoietic cells to neomycin resistance.
A higher level of expression of the CAT gene in hematopoietic cells transformed with SV-CAT compared to those in which the CAT gene was introduced by DNAmediated transfer may reflect more efficient transfer of the viral genome across the cell membrane, more effective delivery of virally introduced DNA to the cell nucleus, or intranuclear amplification of the viral genome. Human cells are semipermissive for SV40 (29, 30) and therefore the presence of wild-type SV40 capable of generating T antigen in the recombinant stocks may allow amplification of SV-CAT in human cells, thereby contributing to the high levels of enzyme activity. For comparison, both pUSV-CAT and a recombinant genome containing an intact early region were introduced into hematopoietic cells to control for the ability of T antigen to amplify circular DNA molecules containing a SV40 early region (18) . Also, mouse cells are generally considered to be nonpermissive for SV40 infection (31) and yet these cells exhibited higher levels of CAT activity after infection with SV40 compared to levels observed after DNA-mediated gene transfer. Poison sequences that may inhibit replication of plasmid molecules containing a SV40 Proc. Natl. Acad. Sci. USA 82 (1985) origin (32) have been partially removed from the pUC vectors (33 The recombinant adenovirus containing the neomycinresistance marker has been successfully used to transform CV1 monkey kidney cells and Rat2 cells to G418 resistance (15) . Integration of one to three copies of linear intact adenoviral genome was observed in these cell lines. Similar transformation and integration of the recombinant adenoviral genome into both human and mouse hematopoietic cell lines was readily achieved, suggesting recombinant adenoviral stocks may be capable of high efficiency gene transfer into cells of diverse origin. Several modifications could enhance gene transfer efficiency. No attempt was made in these initial experiments to achieve an optimal multiplicity of infection. Use of other promoters, for example the Rous long terminal repeat promoter, may also enhance transformation efficiency, as has already been shown in experiments that utilized the DNA transfection methodology (34) . The finding of adenoviral sequences in control K562 cells was unexpected; expression of these sequences could have altered the transformation frequency.
The transformation frequency of the adenovirus recombinants in these initial experiments is lower (by a factor of 100-500) than the 0.3% transformation frequency obtained with the Moloney murine leukemia recombinant virus containing the neomycin-resistance gene (6) . However, when compared to retroviral vectors, the adenovirus system has two major advantages. First, the adenovirus does not remove intron sequences and no inhibition effects of promoter sequences or polyadenylylation signals have been reported to date using adenovirus recombinants. This should allow the adenovirus to accommodate inserts of eukaryotic genes with their own promoter, intervening, and polyadenylylation sequences. Second, two transcriptional units (a total of 6 kb) may potentially be inserted into the El and E3 region of the adenovirus and will thus be separated by -20 kb of relatively inactive DNA. A selectable marker and a test gene could therefore in theory be inserted into the same adenovirus recombinant to study tissue-specific regulation of the test gene-for example, a globin gene in hematopoietic cells.
